Canada NewsWire
OTTAWA, June 16, 2017
OTTAWA, June 16, 2017 /CNW/ - Kinaxis® (TSX:KXS), provider of RapidResponse®, the leading cloud-based concurrent planning solution, announced today that all of management's
nominees listed in the management information circular of the company dated May 11, 2017 were
elected as directors of Kinaxis to hold office until the next annual meeting of shareholders or until their successors are
elected or appointed.
The results of the votes for the election of directors held at Kinaxis' Annual and Special Meeting of Shareholders on
June 15, 2017 are set out below.
|
Name of Nominee
|
Number of Votes Cast by
Proxy and Show of Hands
|
Total Number of Votes
"For"
|
|
Douglas Colbeth
|
19,466,649
|
18,951,456
|
|
John (Ian) Giffen
|
19,466,649
|
19,176,016
|
|
Ronald Matricaria
|
19,466,649
|
19,288,523
|
|
Angel Mendez
|
19,466,649
|
19,186,776
|
|
Jill Denham
|
19,466,649
|
19,307,141
|
|
Robert Courteau
|
19,466,649
|
18,745,504
|
|
John Sicard
|
19,466,649
|
19,296,683
|
Shareholders also approved and ratified the New Canadian Resident Stock Option Plan and the New Non-Canadian Resident Stock
Option Plan of Kinaxis.
Final voting results on all matters voted on at the 2017 Annual and Special Meeting of Shareholders have been filed with
Canadian securities regulators.
About Kinaxis Inc.
Offering the industry's only concurrent planning solution, Kinaxis helps organizations around the world revolutionize their
supply chain planning. Kinaxis RapidResponse, our cloud-based supply chain management software, connects your data, processes and
people into a single harmonious environment. With a consolidated view of the entire supply chain, you can plan expected
performance, monitor progress and respond to disconnects when reality hits. RapidResponse lets you know sooner and act faster,
leading to reduced decision latency, and improved operational and financial performance. We can prove it. From implementation to
expansion, we help our customers with every step of their supply chain journey.
SOURCE Kinaxis
View original content: http://www.newswire.ca/en/releases/archive/June2017/16/c2266.html